MARKET

MRVI

MRVI

Maravai Lifesciences Holdings, Inc.
NASDAQ
2.100
+0.140
+7.14%
After Hours: 2.120 +0.02 +0.95% 17:36 05/16 EDT
OPEN
1.970
PREV CLOSE
1.960
HIGH
2.120
LOW
1.950
VOLUME
1.86M
TURNOVER
--
52 WEEK HIGH
11.56
52 WEEK LOW
1.665
MARKET CAP
534.78M
P/E (TTM)
-1.8285
1D
5D
1M
3M
1Y
5Y
1D
Maravai LifeSciences Q1 2025 Earnings Call: Growth Amid Challenges
TipRanks · 2d ago
TriLink and IVI Collaborate To Advance Research And Development Of mRNA-Based Vaccines And Promote Equitable Access To Essential Vaccines And Health Technologies
Benzinga · 3d ago
Optimistic Growth Outlook for Maravai Lifesciences Holdings Despite Challenges
TipRanks · 3d ago
These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results
Benzinga · 4d ago
Maravai LifeSciences Is Maintained at Buy by Craig-Hallum
Dow Jones · 4d ago
Maravai LifeSciences Price Target Cut to $10.00/Share From $12.00 by Craig-Hallum
Dow Jones · 4d ago
Craig-Hallum Maintains Buy on Maravai LifeSciences, Lowers Price Target to $10
Benzinga · 4d ago
Assessing Maravai LifeSciences: Insights From 5 Financial Analysts
Benzinga · 4d ago
More
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.

Webull offers Maravai Lifesciences Holdings Inc stock information, including NASDAQ: MRVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRVI stock methods without spending real money on the virtual paper trading platform.